Sunstone Life Science Ventures is an independent European venture capital investment firm founded in 2007 by an international team of industry experts with combined entrepreneurial, operational, and financial experience. Managing total funds of approximately €500 million, Sunstone focuses on developing and expanding early-stage life science companies with strong potential to achieve global success in their markets. Since inception, Sunstone has invested in more than 45 companies in the areas of pharmaceuticals, medical technologies, and diagnostics, and has completed more than 20 successful IPOs and large M&A transactions.
Is Sunstone Life Science Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Sunstone Life Science Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€1,000,000 - €10,000,000
When engaging Sunstone Life Science Ventures, founders should highlight breakthrough science, robust clinical validation plans, and a clear path to significant market impact. Demonstrate how your team’s expertise and execution track record can drive a novel solution from early-stage development to global scale. Articulate the unmet medical need and your strategy for navigating regulatory and commercial hurdles, as Sunstone values ventures with both scientific rigor and commercial vision.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.